ATE449863T1 - Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese - Google Patents

Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese

Info

Publication number
ATE449863T1
ATE449863T1 AT06754661T AT06754661T ATE449863T1 AT E449863 T1 ATE449863 T1 AT E449863T1 AT 06754661 T AT06754661 T AT 06754661T AT 06754661 T AT06754661 T AT 06754661T AT E449863 T1 ATE449863 T1 AT E449863T1
Authority
AT
Austria
Prior art keywords
protein synthesis
accuracy
lepa
improve
vitro protein
Prior art date
Application number
AT06754661T
Other languages
English (en)
Inventor
Knud Nierhaus
Yan Qin
Daniel Wilson
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE449863T1 publication Critical patent/ATE449863T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06754661T 2005-07-04 2006-07-04 Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese ATE449863T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05014471 2005-07-04
PCT/EP2006/006503 WO2007003410A1 (en) 2005-07-04 2006-07-04 Use of lepa for improving the accuracy of protein synthesis in vitro

Publications (1)

Publication Number Publication Date
ATE449863T1 true ATE449863T1 (de) 2009-12-15

Family

ID=36953879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06754661T ATE449863T1 (de) 2005-07-04 2006-07-04 Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese

Country Status (6)

Country Link
US (1) US20080187963A1 (de)
EP (1) EP1899474B1 (de)
JP (1) JP2009500025A (de)
AT (1) ATE449863T1 (de)
DE (1) DE602006010704D1 (de)
WO (1) WO2007003410A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008046584A2 (en) * 2006-10-16 2008-04-24 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften Lepa as a target for antibacterial agents
WO2021097349A1 (en) * 2019-11-15 2021-05-20 Machine Bio Inc. Methods and systems for generating biological molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2148649C1 (ru) * 1998-03-31 2000-05-10 Институт белка РАН Способ получения полипептидов в бесклеточной системе (варианты) и устройство для его осуществления

Also Published As

Publication number Publication date
EP1899474A1 (de) 2008-03-19
WO2007003410A1 (en) 2007-01-11
EP1899474B1 (de) 2009-11-25
JP2009500025A (ja) 2009-01-08
US20080187963A1 (en) 2008-08-07
DE602006010704D1 (de) 2010-01-07

Similar Documents

Publication Publication Date Title
MX2018005512A (es) Agentes de union de esclerostina.
BR112012008624A2 (pt) inibidores de tirosina quinase de bruton
NO20043259L (no) Bindingsproteiner som biosensorer
NO20043245L (no) Bindingsproteiner som biosensorer
ATE513833T1 (de) Thienopyridinverbindungen und verfahren zu ihrer verwendung
CL2011000010A1 (es) Anticuerpo monoclonal anti-peptido beta-amiloide; polinucleotido que lo codifica; hibridoma; metodo de produccion; composicion que lo comprende; uso para tratar enfermedades relacionadas con proteinas amiloides; metodo de diagnostico de las mismas; y kit que lo comprende.
EA200801531A1 (ru) Способы регулирования содержания маннозы в рекомбинантных белках
MY151036A (en) Synthesis of (r)-n-methylnaltrexone
DE602006017365D1 (de) Zusammensetzungen für die identifizierung von adenoviren
MX373170B (es) Variantes de la familia il-1.
ATE463512T1 (de) Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
ATE483018T1 (de) Neue fluoreszenzproteine und verfahren zur verwendung davon
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
ATE445402T1 (de) Neue verwendung von pde5-hemmern
DE60142861D1 (de) Verwendung von IL-10 Rezeptor beta antagonistische Antikörper zur Hemmung einer IL-TIF/IL-21 Induktion von Akutphasen-Proteine
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
DE602006017882D1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
WO2006079057A3 (en) Methods and compositions for specific inhibition of protein splicing by small molecules
DE602006010704D1 (de) Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese
DE502007003652D1 (de) Verwendung von nitratsalzen zur unterdrückung störender gerüche
EP2647609A3 (de) Glutaminreiche Peptide als Luftporenbildner in Baustoffmassen
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
BRPI0409557B8 (pt) proteína recombinante inibidora de calicreína, sequência de dna, vetor de expressão, composição farmacêutica, uso da composição farmacêutica, método de produção da proteína recombinanete e kits de diagnóstico
DE602004023939D1 (de) Kristalliner vap-1 und verwendung
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties